cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $1.74 million. The enterprise value is $3.46 million.
Important Dates
The next estimated earnings date is Friday, December 20, 2024, after market close.
| Earnings Date | Dec 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 3.84 million shares outstanding. The number of shares has increased by 38.45% in one year.
| Current Share Class | 3.84M |
| Shares Outstanding | 3.84M |
| Shares Change (YoY) | +38.45% |
| Shares Change (QoQ) | +21.34% |
| Owned by Insiders (%) | 12.80% |
| Owned by Institutions (%) | 5.07% |
| Float | 3.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.35 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 5.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 1.36.
| Current Ratio | 0.93 |
| Quick Ratio | 0.42 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -228.62 |
Financial Efficiency
Return on equity (ROE) is -135.07% and return on invested capital (ROIC) is -19.95%.
| Return on Equity (ROE) | -135.07% |
| Return on Assets (ROA) | -15.71% |
| Return on Capital (ROIC) | -19.95% |
| Revenue Per Employee | $396,857 |
| Profits Per Employee | -$450,467 |
| Employee Count | 52 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 1.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.81% in the last 52 weeks. The beta is 1.99, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | -30.81% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 45.32 |
| Average Volume (20 Days) | 179,485 |
Short Selling Information
The latest short interest is 280,762, so 7.31% of the outstanding shares have been sold short.
| Short Interest | 280,762 |
| Short Previous Month | 183,987 |
| Short % of Shares Out | 7.31% |
| Short % of Float | 8.39% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
In the last 12 months, cbdMD had revenue of $20.64 million and -$23.42 million in losses. Loss per share was -$8.02.
| Revenue | 20.64M |
| Gross Profit | 13.09M |
| Operating Income | -5.88M |
| Pretax Income | -21.65M |
| Net Income | -23.42M |
| EBITDA | -4.35M |
| EBIT | -5.88M |
| Loss Per Share | -$8.02 |
Full Income StatementBalance Sheet
The company has $2.40 million in cash and $4.11 million in debt, giving a net cash position of -$1.71 million or -$0.45 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 4.11M |
| Net Cash | -1.71M |
| Net Cash Per Share | -$0.45 |
| Equity (Book Value) | 3.03M |
| Book Value Per Share | 0.80 |
| Working Capital | -567,610 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$783,670 and capital expenditures -$300,195, giving a free cash flow of -$1.08 million.
| Operating Cash Flow | -783,670 |
| Capital Expenditures | -300,195 |
| Free Cash Flow | -1.08M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 63.43%, with operating and profit margins of -28.50% and -94.12%.
| Gross Margin | 63.43% |
| Operating Margin | -28.50% |
| Pretax Margin | -94.12% |
| Profit Margin | -94.12% |
| EBITDA Margin | -21.09% |
| EBIT Margin | -28.50% |
| FCF Margin | -7.95% |